Literature DB >> 30985989

ATP Inhibits the Transcription Factor STAT5b.

Angela Berg1, Bianca Sperl2, Thorsten Berg1.   

Abstract

Although naturally occurring low-molecular-weight compounds have many known roles within the cell, these do not usually involve the direct inhibition of protein-protein interactions. Based on the results of high-throughput screening of a library of bioactive compounds and neurotransmitters, we report here that the four nucleoside triphosphates ATP, GTP, CTP and UTP inhibit the SH2 domain of the tumor-related transcription factor STAT5b. ATP and GTP are the most active nucleoside triphosphates and show specificity for STAT5b over STAT5a, STAT3, STAT6 and the p53-binding protein HDM2. As the inhibition constant of ATP against STAT5b is significantly lower than published values for the intracellular ATP concentration, our data suggest that ATP might inhibit the protein-protein interactions of STAT5b in living cells.
© 2019 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  SH2 domain; bioactive compounds; inhibitors; nucleotides; protein-protein interactions

Year:  2019        PMID: 30985989     DOI: 10.1002/cbic.201900173

Source DB:  PubMed          Journal:  Chembiochem        ISSN: 1439-4227            Impact factor:   3.164


  3 in total

Review 1.  STAT5A and STAT5B-Twins with Different Personalities in Hematopoiesis and Leukemia.

Authors:  Barbara Maurer; Sebastian Kollmann; Judith Pickem; Andrea Hoelbl-Kovacic; Veronika Sexl
Journal:  Cancers (Basel)       Date:  2019-11-04       Impact factor: 6.639

2.  The Selectivity of Fosfosal for STAT5b over STAT5a is Mediated by Arg566 in the Linker Domain.

Authors:  Julian Gräb; Thorsten Berg
Journal:  Chembiochem       Date:  2020-05-08       Impact factor: 3.164

3.  Stafia-1: a STAT5a-Selective Inhibitor Developed via Docking-Based Screening of in Silico O-Phosphorylated Fragments.

Authors:  Kalaiselvi Natarajan; Daniel Müller-Klieser; Stefan Rubner; Thorsten Berg
Journal:  Chemistry       Date:  2019-11-27       Impact factor: 5.236

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.